EMPLOYMENT AGREEMENTEmployment Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
This Employment Agreement (this “Agreement”), is made and entered into as of the 31st day of March, 2006 (the “Effective Date”), by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (“Employer”), and KENNETH S. KORNMAN, an individual (“Employee”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Massachusetts
This Amended and Restated Employment Agreement (this “Agreement”), is made and entered into as of the 31st day of March, 2006 (the “Effective Date”), by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (“Employer” or “Company”), and PHILIP R. REILLY, an individual (“Employee”), and amends the Employment Agreement between Employer and Employee originally dated April 1, 2000 and amended on March 5, 2003 and March 1, 2006.
AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
THIS AMENDMENT (the “Amendment”), dated as of March 6, 2006, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (“Employer”), and PHILIP R. REILLY, an individual (“Employee”). Employer and Employee are parties to an Employment Agreement, dated April 1, 2000 (the “Employment Agreement”). Terms not otherwise defined in this Amendment shall have the meanings given to them in the Employment Agreement.
AMENDMENT NO. 4 TO NOTE PURCHASE AGREEMENTNote Purchase Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 4 (the “Amendment”), dated as of February 23, 2006, is by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (the “Company”), and PYXIS INNOVATIONS INC., a Delaware corporation (“Pyxis”).
PURCHASE AGREEMENTPurchase Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
THIS PURCHASE AGREEMENT (the “Agreement”) is made effective as of March 23, 2006, between ACCESS BUSINESS GROUP INTERNATIONAL LLC, acting as agent for ACCESS BUSINESS GROUP LLC (“Access”), a Michigan limited liability company, having its principal office at 7575 East Fulton Road, Ada, Michigan 49355, United States; and INTERLEUKIN GENETICS, INC., a Delaware corporation having its principal office at 135 Beaver Street, Waltham, MA 02453 (“Seller”). Access and Seller may also be referred to separately as a “party” and collectively as “parties.”
PURCHASE AGREEMENTPurchase Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Michigan
THIS PURCHASE AGREEMENT (the “Agreement”) is made effective as of January 31, 2006, (the “Effective Date”) between ACCESS BUSINESS GROUP INTERNATIONAL LLC, acting as agent for ACCESS BUSINESS GROUP LLC (“Access”), a Michigan limited liability company, having its principal office at 7575 East Fulton Road, Ada, Michigan 49355, United States; and INTERLEUKIN GENETICS, INC., a Delaware corporation having its principal office at 135 Beaver Street, Waltham, MA 02453 (“Seller”). Access and Seller may also be referred to separately as a “party” and collectively as “parties.”
AMENDMENT NO. 3 TO EMPLOYMENT AGREEMENTEmployment Agreement • May 10th, 2006 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances
THIS AMENDMENT (the “Amendment”), dated as of March 6, 2006, is made by and between INTERLEUKIN GENETICS, INC., a Delaware corporation (“Employer”), and KENNETH S. KORNMAN., an individual (“Employee”). Employer and Employee are parties to an Employment Agreement, dated December 1, 1999 (the “Employment Agreement”). Terms not otherwise defined in this Amendment shall have the meanings given to them in the Employment Agreement.
